Electronic cigarette, or vaping, product use-associated lung injury (EVALI) in a patient with testicular cancer: A case report
- PMID: 37165581
- PMCID: PMC10702303
- DOI: 10.1177/03008916231172806
Electronic cigarette, or vaping, product use-associated lung injury (EVALI) in a patient with testicular cancer: A case report
Abstract
Electronic cigarette, or vaping, product use-associated lung injury (EVALI) is an increasingly recognized entity with the potential for severe pulmonary toxicity. We present the case of a young man first evaluated at a tertiary care center in the United States in 2019 with newly diagnosed testicular cancer with acute respiratory failure, which was initially attributed to possible metastatic disease but eventually determined to be related to EVALI. This case highlights the clinical features of EVALI, the potential diagnostic dilemma that can arise with EVALI when occurring in the setting of malignancy and the importance of inquiring about vaping use among patients with malignancy, especially in adolescents and young adults.
Keywords: Vaping; case report; e-cigarette; lung injury; testicular cancer.
Conflict of interest statement
Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
References
-
- FDA. Respiratory illnesses associated with use of vaping products. US Food and Drug Administration. FDA, http://www.fda.gov/news-events/public-health-focus/lung-illnesses-associ... (2020, accessed 2 February 2023).
-
- Layden JE, Ghinai I, Pray I, et al.. Pulmonary illness related to E-cigarette use in Illinois and Wisconsin - final report. N Engl J Med 2020; 382: 903–916. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
